Biohaven Ltd (BHVN)
45.16
-0.03
(-0.07%)
USD |
NYSE |
Nov 22, 15:47
Biohaven Shareholders Equity (Quarterly): 316.01M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 316.01M |
| June 30, 2024 | 383.74M |
| March 31, 2024 | 301.45M |
| December 31, 2023 | 427.98M |
| September 30, 2023 | 290.01M |
| June 30, 2023 | 387.26M |
| Date | Value |
|---|---|
| March 31, 2023 | 472.26M |
| December 31, 2022 | 538.77M |
| September 30, 2022 | 100.22M |
| June 30, 2022 | 262.23M |
| December 31, 2021 | 34.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
34.69M
Minimum
Dec 2021
538.77M
Maximum
Dec 2022
319.51M
Average
316.01M
Median
Sep 2024
Shareholders Equity (Quarterly) Benchmarks
| Scholar Rock Holding Corp | 79.20M |
| Veru Inc | 37.62M |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Vanda Pharmaceuticals Inc | 541.22M |
| Oramed Pharmaceuticals Inc | 156.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 510.52M |
| Total Liabilities (Quarterly) | 194.52M |